Literature DB >> 35089488

Evaluation of Hyperandrogenism in Children with Autism Spectrum Disorder.

Neeharika Sriram1, Priyanka Madaan2, Prahbhjot Malhi3, Naresh Sachdeva4, Sandeep Negi2, Jhumki Das2, Rakesh Kumar5, Jitendra Kumar Sahu6, Pratibha Singhi2.   

Abstract

This study evaluated 32 children (mean age: 8.5 y) with autism spectrum disorder (ASD) and 23 healthy controls (similar age, sex, and Tanner stage) for hyperandrogenism. These children underwent sexual maturity rating (Tanner staging), ASD severity assessment (Childhood Autism Rating Scale), and quantitative estimation for plasma testosterone, dehydroepiandrosterone sulfate (DHEAS), and androstenedione. There was no significant difference in androgen levels in the two groups. Elevated (> 95 centiles) testosterone, DHEAS, and androstenedione levels were seen in 12.3%, 6.2%, and 9% children with ASD, and 7/9 of these children (78%) with hyperandrogenism had severe ASD. However, there was no significant correlation between ASD severity and androgen levels.
© 2022. Dr. K C Chaudhuri Foundation.

Entities:  

Keywords:  Autism; Children; Hyperandrogenism

Mesh:

Substances:

Year:  2022        PMID: 35089488     DOI: 10.1007/s12098-022-04080-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   5.319


  3 in total

1.  Serum testosterone concentration in male autistic youngsters.

Authors:  Jan Croonenberghs; Sarah Van Grieken; Annick Wauters; Dirk Van West; Lucas Brouw; Michael Maes; Dirk Deboutte
Journal:  Neuro Endocrinol Lett       Date:  2010       Impact factor: 0.765

2.  A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies.

Authors:  David A Geier; Mark R Geier
Journal:  Neuro Endocrinol Lett       Date:  2007-10       Impact factor: 0.765

3.  Prevalence of autism spectrum disorder in Indian children: A systematic review and meta-analysis.

Authors:  Anil Chauhan; Jitendra K Sahu; Nishant Jaiswal; Kiran Kumar; Amit Agarwal; Jasleen Kaur; Sukhmanjeet Singh; Meenu Singh
Journal:  Neurol India       Date:  2019 Jan-Feb       Impact factor: 2.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.